Merck & Co Inc

NYSE: MRK
$116.44
-$0.73 (-0.6%)
Real Time Data Delayed 15 Min.

MRK Articles

SunTrust Robinson Humphrey analysts expect the pharmaceutical industry to outperform in 2015, driven in part by a solid new product cycle and an attractive five-year growth rate.
thinkstockMarch 18, 2015: Markets opened lower on Wednesday and bided its time below the break-even line until just after 2 p.m. and the FOMC’s announcement that it would no longer wait patiently...
A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to outperform this year.
With AT&T dropped from the Dow in favor of Apple, investors may be wondering which Dow stocks could get booted from the index next.
thinkstock February 9, 2015: Markets opened lower on Monday following remarks by Greece’s new president that rattled traders. There was no U.S. economic data out today. Shortly before the closing...
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
Merck reported largely in-line fourth-quarter financial results Wednesday before the U.S. markets opened.
24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming week.
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
One key consideration for the year ahead is Merck's acquisitions of Idenix and Cubist Pharmaceuticals to expand its product offerings
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
thinkstockJanuary 7, 2015: Markets opened higher on Wednesday after ADP and TrimTab reports on unemployment came in a shade above expectations. The U.S. trade balance improved in November primarily...
A new resort from UBS highlights the firm's first Equity Focus list for 2015. Here are five of the highest yielding dividend stocks on the list.
Monday's top analyst upgrades, downgrades and initiations include Akamai Technologies, Carnival, Chevron, El Pollo Loco, Ford, F5 Networks, Lululemon Athletica and Starbucks.